Ischemic Preconditioning in White Matter: Magnitude and Mechanism
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Ischemic preconditioning (IPC) is a robust neuroprotective phenomenon whereby brief ischemic exposure confers tolerance to a subsequent ischemic challenge. IPC has not been studied selectively in CNS white matter (WM), although stroke frequently involves WM. We determined whether IPC is present in WM and, if so, its mechanism. We delivered a brief in vivo preconditioning ischemic insult (unilateral common carotid artery ligation) to 12- to 14-week-old mice and determined WM ischemic vulnerability [oxygen–glucose deprivation (OGD)] 72 h later, using acutely isolated optic nerves (CNS WM tracts) from the preconditioned (ipsilateral) and control (contralateral) hemispheres. Functional and structural recovery was assessed by quantitative measurement of compound action potentials (CAPs) and immunofluorescent microscopy. Preconditioned mouse optic nerves (MONs) showed better functional recovery after OGD than the non-preconditioned MONs (31 ± 3 vs 17 ± 3% normalized CAP area,p< 0.01). Preconditioned MONs also showed improved axon integrity and reduced oligodendrocyte injury compared with non-preconditioned MONs. Toll-like receptor-4 (TLR4) and type 1 interferon receptor (IFNAR1), key receptors in innate immune response, are implicated in gray matter preconditioning. Strikingly, IPC-mediated WM protection was abolished in both TLR4−/−and IFNAR1−/−mice. In addition, IPC-mediated protection in WM was also abolished in IFNAR1 fl/fl LysM cre, but not in IFNAR1 fl/flcontrol, mice. These findings demonstrated for the first time that IPC was robust in WM, the phenomenon being intrinsic to WM itself. Furthermore, WM IPC was dependent on innate immune cell signaling pathways. Finally, these data demonstrated that microglial-specific expression of IFNAR1 plays an indispensable role in WM IPC. SIGNIFICANCE STATEMENT Ischemic preconditioning (IPC) has been studied predominantly in gray matter, but stroke in humans frequently involves white matter (WM) as well. Here we describe a novel, combined in vivo/ex vivo mouse model to determine whether IPC occurs in WM. It does. Using genetically altered mice, we identified two innate immune cell receptors, Toll-like receptor 4 and type 1 interferon receptor (IFNAR1), that are required for IPC-mediated protection in WM. Furthermore, using microglia-targeted IFNAR1 knockdown, we demonstrate that interferon signaling specifically in microglia is essential for this protection. The discovery of IPC as an intrinsic capability of WM is novel and important. This is also the first in vivo demonstration that cell-type-specific expression of an individual gene plays an indispensable role in IPC-mediated protection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Family of AMPA-Selective Glutamate Receptors
Keinänen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Verdoorn, T. A., Sakmann, B., & Seeburg, P. H. (1990) · Science · doi:10.1126/science.2166337 · Cited by 1,479 · cited 7×
“The physiological function of the channel is determined by both the composition of the subunits of the receptor and flip/ flop isoforms that can affect channel open time and possibly injury severity (Keinänen et al., 1990; Sommer et al., 1990).”
BackgroundInfluentialType I interferon is selectively required by dendritic cells for immune rejection of tumors
Diamond, M. S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G. P., Archambault, J. M., Lee, H., Arthur, C. D., White, J. M., Kalinke, U., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101158 · Cited by 1,081
Cerebral preconditioning and ischaemic tolerance
Gidday, J. M. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1927 · Cited by 751 · cited 2×
“Elucidating the mechanisms of IPC is a critical challenge in stroke research (Gidday, 2006).”
BackgroundType I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia
Kamphuis, E., Junt, T., Waibler, Z., Forster, R., & Kalinke, U. (2006) · Blood · doi:10.1182/blood-2006-06-027599 · Cited by 306
Stys, P. K., Ransom, B. R., & Waxman, S. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91154-s · Cited by 195
Stenzel-Poore, M. P., Stevens, S. L., King, J. S., & Simon, R. P. (2007) · Stroke · doi:10.1161/01.str.0000251444.56487.4c · Cited by 192
Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke
Shichita, T., Ago, T., Kamouchi, M., Kitazono, T., Yoshimura, A., & Ooboshi, H. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07941.x · Cited by 136 · cited 1×
“Ischemia is presumed to cause release of endogenous TLR4 agonists (including heat shock proteins, high mobility group box 1, and peroxiredoxins), sometimes called “danger-associated molecular pattern” (DAMP) molecules, activating TLR4 on resident microglia, astrocytes or infiltrating macrophages (Weinstein et al., 201…”
BackgroundSu, W., Hopkins, S., Nesser, N. K., Sopher, B., Silvestroni, A., Ammanuel, S., Jayadev, S., Möller, T., Weinstein, J., & Garden, G. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301397 · Cited by 103
Self-citationBahjat, F. R., Williams-Karnesky, R. L., Kohama, S. G., West, G. A., Doyle, K. P., Spector, M. D., Hobbs, T. R., & Stenzel-Poore, M. P. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.6 · Cited by 51 · cited 5×
“Furthermore, pretreatment of mice with either pharmacologic agonists targeting TLRs (Bahjat et al., 2011; Gesuete et al., 2012; Leung et al., 2012; Packard et al., 2012) or preexposure to interferon- itself (Stevens et al., 2011) induces robust neuroprotection against subsequent cerebral ischemic injury.”
BackgroundInfluential
Cited by
Decoding the Transcriptional Response to Ischemic Stroke in Young and Aged Mouse Brain
Androvic, P., Kirdajova, D., Tureckova, J., Zucha, D., Rohlova, E., Abaffy, P., Kriska, J., Valny, M., Anderova, M., Kubista, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107777 · Cited by 118
Main, B. S., Zhang, M., Brody, K. M., Ayton, S., Frugier, T., Steer, D., Finkelstein, D., Crack, P. J., & Taylor, J. M. (2016) · Glia · doi:10.1002/glia.23028 · Cited by 92
Ischemia/reperfusion induces interferon stimulated gene expression in microglia
McDonough, A., Lee, R. V., Noor, S., Lee, C., Le, T., Iorga, M., Phillips, J. L. H., Murphy, S., Möller, T., & Weinstein, J. R. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0725-17.2017 · Cited by 71
“…(Prinz et al., 2008; Khorooshi and Owens, 2010; Brendecke and Prinz, 2012; Owens et al., 2014) and type I IFNs are implicated in experimental neuroprotective phenomena such as lipopolysaccharide (LPS) (Marsh et al., 2009) and ischemic (Stevens et al., 2011; Hamner et al., 2015) preconditioning.”
BackgroundSelf-citation
Metadata
- Authors
- Hamner, M. A., Ye, Z., Lee, R. V., Colman, J. R., Le, T., Gong, D. C., Ransom, B. R., & Weinstein, J. R.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2015-11-25
- Volume
- 35
- Issue
- 47
- Pages
- 15599-15611
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2187114150
- Cited by
- 47
- References
- 9
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ischemic Preconditioning in White Matter: Magnitude and Mechanism. https://app.cochat.ai/papers/10.1523/jneurosci.2544-15.2015
- The paper
- Hamner, M. A., Ye, Z., Lee, R. V., Colman, J. R., Le, T., Gong, D. C., Ransom, B. R., & Weinstein, J. R. (2015). Ischemic Preconditioning in White Matter: Magnitude and Mechanism. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.2544-15.2015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.